Pharmaceutical Executive
A night of comedy in support of a chronic disease.
The best comedians can seamlessly transition from one subject to just about any other, but it was jarring to go from Larry Hausner, CEO of the American Diabetes Association, and the harrowing statistics he presented—along with silhouetted patients entering the stage every 17 seconds, symbolizing the frequency of new diabetes diagnoses—to New York comedians Colin Quinn and Jerry Seinfeld. Luckily, the ever-ebullient Fox New York television anchor Rosanna Scotto, and Novo Nordisk's Camille Lee, SVP, US diabetes marketing (Novo sponsored the concert, and a pre-party held nearby) helped keep the packed theater from getting too depressed before the comedians took the stage.
Ben Comer
It was the third time Seinfeld has performed at a Stand Up for a Cure show (SUFAC), and the April 17 event at The Theater in Madison Square Garden represented the first of a series of shows happening under the SUFAC name this year. The Seinfeld/Quinn double bill for charity brought out famous and not so famous celebrities, including Martha Stewart, Sasha Cohen (the Olympian figure skater, not Borat), and several Real Housewives of New York, in addition to diabetes activists and bloggers. Neither Quinn nor Seinfeld did any jokes on diabetes specifically, although Quinn worried about New York City Mayor Michael Bloomberg's legacy, which is lamentably switching from the guy who cleaned all the guns off the streets of New York, to the guy who took away extra-large sodas.
Left to right: Camille Lee, SVP, US diabetes marketing; Diana Blankman, director, US corporate giving and social impact; Jerry Seinfeld; and Antonio Coppola, director of corporate relations, ADA.
The evidently soda-loving Quinn also had some choice remarks on how much Brooklyn has changed since he was a kid: "It used to be tough Italian guys with tattoos and wife-beaters...now it's young women with tattoos and wife-beaters." Seinfeld riffed on being married with children, and dusted off a couple of old digs on televised drug ads. After viewing an ad for Lilly's erectile dysfunction drug Cialis with his children, Seinfeld said he had to explain that an erection is "like an erector set." Seinfeld said he understood why the couple in the Cialis commercial was having intimacy problems; they'd just carried two extremely heavy cast iron bathtubs all the way up a hill to watch the sunset, without plumbing. On the oft-japed four-hour erection warning, Seinfeld worried about the awkwardness of the hospital waiting room in that situation (he advised wearing a parka), and then, what a physician would actually do about it.
Jerry Seinfeld performing at Stand Up for a Cure.
From all appearances, the event was a success, and the idea of employing comedians to help raise funds for research into cures for deadly diseases is a good one. Chronic disease isn't funny, of course, but laughing beats crying.
Ben Comer is Pharm Exec's Senior Editor. He can be reached at bcomer@advanstar.com.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.